Local strategies and delivery systems for the treatment of malignant gliomas

References

• Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012;205:613–621.
   PubMed Web of Science ®Google Scholar
• Parisi S, Corsa P, Raguso A, et al. Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review. Biomed Res Int. 2015;2015:1–7.
   Google Scholar
• Wang Z, Yang G, Zhang YY, et al. A comparison between oral chemotherapy combined with radiotherapy and radiotherapy for newly diagnosed glioblastoma: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96:e8444.
   PubMed Web of Science ®Google Scholar
• Groothuis DR. The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro-oncol. 2000;2:45–59.
   PubMed Web of Science ®Google Scholar
• Rautio J, Laine K, Gynther M, et al. Prodrug approaches for CNS delivery. Aaps J. 2008;10:92–102.
   PubMed Web of Science ®Google Scholar
• Scherrmann JM. Drug delivery to brain via the blood-brain barrier. Vascul Pharmacol. 2002;38:349–354.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Blood-brain barrier delivery. Drug Discov Today. 2007;12:54–61.
   PubMed Web of Science ®Google Scholar
• Rapoport SI, Robinson PJ. Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann N Y Acad Sci. 1986;481:250–267.
   PubMed Web of Science ®Google Scholar
• Nakano S, Matsukado K, Black KL. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res. 1996;56:4027–4031.
   PubMed Web of Science ®Google Scholar
• Neuwelt EA, Frenkel EP, Rapoport S, et al. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neurosurgery. 1980;7:36–43.
   PubMed Web of Science ®Google Scholar
• Blasberg RG, Kobayashi T, Horowitz M, et al. Regional blood-to-tissue transport in ethylnitrosourea-induced brain tumors. Ann Neurol. 1983;14:202–215.
   PubMed Web of Science ®Google Scholar
• Zunkeler B, Carson RE, Olson J, et al. Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J Neurosurg. 1996;85:1056–1065.
   PubMed Web of Science ®Google Scholar
• Kanazawa T, Taki H, Tanaka K, et al. Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration. Pharm Res. 2011;28:2130–2139.
   PubMed Web of Science ®Google Scholar
• Li Y, He H, Jia X, et al. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials. 2012;33:3899–3908.
   PubMed Web of Science ®Google Scholar
• Hu K, Shi Y, Jiang W, et al. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease. Int J Pharm. 2011;415:273–283.
   PubMed Web of Science ®Google Scholar
• Lu W, Wan J, She Z, et al. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release. 2007;118:38–53.
   PubMed Web of Science ®Google Scholar
• Dilnawaz F, Singh A, Mewar S, et al. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model. Biomaterials. 2012;33:2936–2951.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang C. Research advances in brain-targeted nanoscale drug delivery system. Acta Pharmaceutica Sinica. 2013;48:1532–1543.
   PubMedGoogle Scholar
• Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology. 1980;30:907–911.
   PubMed Web of Science ®Google Scholar
• Wang PP, Frazier J, Brem H. Local drug delivery to the brain. Adv Drug Deliv Rev. 2002;54:987–1013.
   PubMed Web of Science ®Google Scholar
• Pathan SA, Iqbal Z, Zaidi SM, et al. CNS drug delivery systems: novel approaches. Recent Pat Drug Deliv Formul. 2009;3:71–89.
   PubMedGoogle Scholar
• Bernacki J, Dobrowolska A, Nierwińska K, et al. Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep. 2008;60:600–622.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 2012;64:640–665.
   PubMed Web of Science ®Google Scholar
• Silva GA. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neurosci. 2008;9 (Suppl 3):S4.
   PubMedGoogle Scholar
• Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584–1596.
   PubMed Web of Science ®Google Scholar
• Li JF, Jiang C. Drug delivery systems for glioma specific targeting. J Int Pharm Res. 2013;40:573–583.
   Google Scholar
• Tator CH, Day A, Ng R, et al. Chemotherapy of an experimental glioma with nitrosoureas. Cancer Res. 1977;37:476–481.
   PubMed Web of Science ®Google Scholar
• Sheldon P, Ommaya AK. Ventricular dilatation masking the presence of cerebral tumours. Acta Radiol Diagn (Stockh). 1963;1:628–637.
   PubMedGoogle Scholar
• Boiardi A, Silvani A, Eoli M, et al. Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival? J Neurooncol. 2008;88:105–113.
   PubMed Web of Science ®Google Scholar
• Oshiro S, Tsugu H, Komatsu F, et al. Evaluation of intratumoral administration of tumor necrosis factor-alpha in patients with malignant glioma. Anticancer Res. 2006;26:4027–4032.
   PubMed Web of Science ®Google Scholar
• Torres LA, Coca MA, Batista JF, et al. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas. Nucl Med Commun. 2008;29:66–75.
   PubMed Web of Science ®Google Scholar
• Gaspar LE, Zamorano LJ, Shamsa F, et al. Permanent 125iodine implants for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 1999;43:977–982.
   PubMed Web of Science ®Google Scholar
• Boiardi A, Eoli M, Salmaggi A, et al. New approach in delivering chemotherapy: locoregional treatment for recurrent glioblastoma (rGBM). J Exp Clin Cancer Res. 2003;22:123–127.
   PubMed Web of Science ®Google Scholar
• Prados MD, McDermott M, Chang SM, et al. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial. J Neurooncol. 2003;65:269–278.
   PubMed Web of Science ®Google Scholar
• Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583–592.
   PubMed Web of Science ®Google Scholar
• Bobo RH, Laske DW, Akbasak A, et al. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA. 1994;91:2076–2080.
   PubMed Web of Science ®Google Scholar
• Yang W, Barth RF, Adams DM, et al. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Res. 2002;62:6552–6558.
   PubMed Web of Science ®Google Scholar
• Zhou J, Patel TR, Sirianni RW, et al. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci USA. 2013;110:11751–11756.
   PubMed Web of Science ®Google Scholar
• Allard E, Jarnet D, Vessieres A, et al. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft. Pharm Res. 2010;27:56–64.
   PubMed Web of Science ®Google Scholar
• Inoue T, Yamashita Y, Nishihara M, et al. Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models. Neuro Oncol. 2009;11:151–157.
   PubMed Web of Science ®Google Scholar
• Bernal GM, LaRiviere MJ, Mansour N, et al. Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine. 2014;10:149–157.
   PubMed Web of Science ®Google Scholar
• Chen PY, Ozawa T, Drummond DC, et al. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts. Neuro Oncol. 2013;15:189–197.
   PubMed Web of Science ®Google Scholar
• Vinchon-Petit S, Jarnet D, Paillard A, et al. In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. J Neurooncol. 2010;97:195–205.
   PubMed Web of Science ®Google Scholar
• Linninger AA, Somayaji MR, Mekarski M, et al. Prediction of convection-enhanced drug delivery to the human brain. J Theor Biol. 2008;250:125–138.
   PubMed Web of Science ®Google Scholar
• Bidros DS, Vogelbaum MA. Novel drug delivery strategies in neuro-oncology. Neurotherapeutics. 2009;6:539–546.
   PubMed Web of Science ®Google Scholar
• Raghavan R, Brady ML, Rodriguez-Ponce MI, et al. Convection-enhanced delivery of therapeutics for brain disease, and its optimization. Neurosurg Focus. 2006;20:E12.
   PubMedGoogle Scholar
• Lesniak MS, Upadhyay U, Goodwin R, et al. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res. 2005;25:3825–3831.
   PubMed Web of Science ®Google Scholar
• Ozeki T, Kaneko D, Hashizawa K, et al. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel. Int J Pharm. 2012;427:299–304.
   PubMed Web of Science ®Google Scholar
• Fung LK, Ewend MG, Sills A, et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 1998;58:672–684.
   PubMed Web of Science ®Google Scholar
• Grossman SA, Reinhard C, Colvin OM, et al. The intracerebral distribution of bcnu delivered by surgically implanted biodegradable polymers. J Neurosurg. 1992;76:640–647.
   PubMed Web of Science ®Google Scholar
• Liechty WB, Kryscio DR, Slaughter BV, et al. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149–173.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Gopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev. 2001;48:229–247.
   PubMed Web of Science ®Google Scholar
• Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976;263:797–800.
   PubMed Web of Science ®Google Scholar
• Attenello FJ, Mukherjee D, Datoo G, et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 2008;15:2887–2893.
   PubMed Web of Science ®Google Scholar
• Elstad NL, Fowers KD. OncoGel (ReGel/paclitaxel)–clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev. 2009;61:785–794.
   PubMed Web of Science ®Google Scholar
• Richards Grayson AC, Choi IS, Tyler BM, et al. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nature Mater. 2003;2:767–772.
   PubMed Web of Science ®Google Scholar
• Sawyer AJ, Piepmeier JM, Saltzman WM. New methods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med. 2006;79:141–152.
   PubMedGoogle Scholar
• Satilmis G, Zella SMA, Wallocha M, et al. Evaluation of complications of Carmustin Wafer implantation in recurrent GBM. Rev Sci Instrum. 2012;77:03A708–03A708-4.
   Google Scholar
• Benny O, Menon LG, Ariel G, et al. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Clin Cancer Res. 2009;15:1222–1231.
   PubMed Web of Science ®Google Scholar
• Neeves KB, Sawyer AJ, Foley CP, et al. Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles. Brain Res. 2007;1180:121–132.
   PubMed Web of Science ®Google Scholar
• Noble CO, Krauze MT, Drummond DC, et al. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res. 2006;66:2801–2806.
   PubMed Web of Science ®Google Scholar
• Dong XW, Mumper RJ. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine. 2010;5:597–615.
   PubMed Web of Science ®Google Scholar
• Yuan XB, Kang CS, Yan CH, et al. Intracranial C6 gliomas suppression by stereotactic injection of BCNU-loaded nanopartides targeting for C6 glioma cells. Chin J of Biomed Eng. 2006;25:765–769.
   Google Scholar
• Nance E, Zhang C, Shih TY, et al. Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano. 2014;8:10655–10664.
   PubMed Web of Science ®Google Scholar
• Mardor Y, Rahav O, Zauberman Y, et al. Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res. 2005;65:6858–6863.
   PubMed Web of Science ®Google Scholar
• Perlstein B, Ram Z, Daniels D, et al. Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring. Neuro Oncol. 2008;10:153–161.
   PubMed Web of Science ®Google Scholar
• Arshad A, Yang B, Bienemann AS, et al. Convection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastoma. PLoS One. 2015;10:e0132266.
   PubMed Web of Science ®Google Scholar
• Drummond DC, Marx C, Guo Z, et al. Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes. Clin Cancer Res. 2005;11:3392–3401.
   PubMed Web of Science ®Google Scholar
• Bing X, Wu L, Huang S, et al. Preliminary study of injection adriamycin liposomes through a thin tube implanted in the brain for treating brain glioma in rats. Chin J Oncol Prev Treat 2015;7:90–94.
   Google Scholar
• Mamot C, Nguyen JB, Pourdehnad M, et al. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol. 2004;68:1–9.
   PubMed Web of Science ®Google Scholar
• Krauze MT, Noble CO, Kawaguchi T, et al. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro Oncol. 2007;9:393–403.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Krauze MT, Kawaguchi T, et al. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro Oncol. 2007;9:20–28.
   PubMed Web of Science ®Google Scholar
• Zhang R, Saito R, Mano Y, et al. Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models. Drug Deliv. 2016;23:2780–2786.
   PubMed Web of Science ®Google Scholar
• Jackson C, Ruzevick J, Phallen J, et al. Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. Clin Dev Immunol. 2011;2011:732413.
   PubMedGoogle Scholar
• Singleton WG, Collins AM, Bienemann AS, et al. Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model. Int J Nanomedicine. 2017;12:1385–1399.
   PubMed Web of Science ®Google Scholar
• Gao S, Li J, Jiang C, et al. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer. Drug Des Devel Ther. 2016;10:1–11.
   PubMed Web of Science ®Google Scholar
• Kang C, Yuan X, Li F, et al. Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo. J Biomed Mater Res A. 2010;93:585–594.
   PubMedGoogle Scholar
• Mendelsohn J. The epidermal growth factor receptor as a target for cancer therapy. Endocr Relat Cancer. 2001;8:3–9.
   PubMed Web of Science ®Google Scholar
• Lammering G, Hewit TH, Holmes M, et al. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity. Clin Cancer Res. 2004;10:6732–6743.
   PubMed Web of Science ®Google Scholar
• Wu G, Barth RF, Yang W, et al. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Mol Cancer Ther. 2006;5:52–59.
   PubMed Web of Science ®Google Scholar
• Lemaire L, Roullin VG, Franconi F, et al. Therapeutic efficacy of 5-fluorouracil-loaded microspheres on rat glioma: a magnetic resonance imaging study. NMR Biomed. 2001;14:360–366.
   PubMed Web of Science ®Google Scholar
• Fournier E, Passirani C, Montero-Menei C, et al. Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats. Cancer. 2003;97:2822–2829.
   PubMed Web of Science ®Google Scholar
• Hagerstrand D, Hesselager G, Achterberg S, et al. Characterization of an imatinib-sensitive subset of high-grade human glioma cultures. Oncogene. 2006;25:4913–4922.
   PubMed Web of Science ®Google Scholar
• Lan F, Yue X, Han L, et al. Antitumor effect of aspirin in glioblastoma cells by modulation of β-catenin/T-cell factor-mediated transcriptional activity. J Neurosurg. 2011;115:780–788.
   PubMed Web of Science ®Google Scholar
• Shi ZD, Qian XM, Liu CY, et al. Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of beta-catenin transactivation. CNS Neurosci Ther. 2013;19:98–108.
   PubMed Web of Science ®Google Scholar
• Panigrahi M, Das PK, Parikh PM. Brain tumor and Gliadel wafer treatment. Indian J Cancer. 2011;48:11–17.
   PubMed Web of Science ®Google Scholar
• Fleming AB, Saltzman WM. Pharmacokinetics of the carmustine implant. Clin Pharmacokinet. 2002;41:403–419.
   PubMed Web of Science ®Google Scholar
• Brem H, Tamargo RJ, Olivi A, et al. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation-therapy in the monkey brain. J Neurosurg. 1994;80:283–290.
   PubMed Web of Science ®Google Scholar
• Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. the polymer-brain tumor treatment group. Lancet. 1995;345:1008–1012.
   PubMed Web of Science ®Google Scholar
• Fung LK, Shin M, Tyler B, et al. Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm Res. 1996;13:671–682.
   PubMed Web of Science ®Google Scholar
• Engelhard HH. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma. Surg Neurol. 2000;53:458–464.
   PubMed Web of Science ®Google Scholar
• Kuramitsu S, Motomura K, Natsume A, et al. Double-edged sword in the placement of carmustine (BCNU) wafers along the eloquent area: a case report. NMC Case Rep J. 2015;2:40–45.
   PubMedGoogle Scholar
• Brem S, Tyler B, Li K, et al. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother Pharmacol. 2007;60:643–650.
   PubMed Web of Science ®Google Scholar
• Harn HJ, Lin SZ, Lin PC, et al. Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas. Neuro-Oncol. 2011;13:635–648.
   PubMed Web of Science ®Google Scholar
• Ashby LS, Smith KA, Stea B. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. World J Surg Onc. 2016;14:225.
   PubMed Web of Science ®Google Scholar
• Arai T, Joki T, Akiyama M, et al. Novel drug delivery system using thermoreversible gelation polymer for malignant glioma. J Neurooncol. 2006;77:9–15.
   PubMed Web of Science ®Google Scholar
• Zentner GM, Rathi R, Shih C, et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release. 2001;72:203–215.
   PubMed Web of Science ®Google Scholar
• Tyler BM, Hdeib A, Caplan J, et al. Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel. J Neurosurg Spine. 2012;16:93–101.
   PubMed Web of Science ®Google Scholar
• Vellimana AK, Recinos VR, Hwang L, et al. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model. J Neurooncol. 2013;111:229–236.
   PubMed Web of Science ®Google Scholar
• Liebmann J, Cook JA, Fisher J, et al. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst. 1994;86:441–446.
   PubMed Web of Science ®Google Scholar
• Elomaa L, Joensuu H, Kulmala J, et al. Squamous cell carcinoma is highly sensitive to taxol, a possible new radiation sensitizer. Acta Otolaryngol. 1995;115:340–344.
   PubMed Web of Science ®Google Scholar
• Bastiancich C, Vanvarenberg K, Ucakar B, et al. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma. J Control Release. 2016;225:283–293.
   PubMed Web of Science ®Google Scholar
• Giese A, Kucinski T, Knopp U, et al. Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma. J Neurooncol. 2004;66:351–360.
   PubMed Web of Science ®Google Scholar
• Kim GY, Tyler BM, Tupper MM, et al. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. J Control Release. 2007;123:172–178.
   PubMed Web of Science ®Google Scholar
• Masi BC, Tyler BM, Bow H, et al. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model. Biomaterials. 2012; 33:5768–5775.
   PubMed Web of Science ®Google Scholar
• Stephen ZR, Kievit FM, Veiseh O, et al. Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors. ACS Nano. 2014;8:10383–10395.
   PubMed Web of Science ®Google Scholar
• Sawyer AJ, Saucier-Sawyer JK, Booth CJ, et al. Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors. Drug Deliv and Transl Res. 2011;1:34–42.
   PubMed Web of Science ®Google Scholar
• Corem-Salkmon E, Ram Z, Daniels D, et al. Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles. Int J Nanomed. 2011;6:1595–1602.
   PubMed Web of Science ®Google Scholar
• Saito R, Krauze MT, Noble CO, et al. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol. 2006;8:205–214.
   PubMed Web of Science ®Google Scholar
• Yokosawa M, Sonoda Y, Sugiyama S, et al. Convection-enhanced delivery of a synthetic retinoid am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts. Tohoku J Exp Med. 2010;221:257–264.
   PubMed Web of Science ®Google Scholar
• Benny O, Kim SK, Gvili K, et al. In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. Faseb J. 2008;22:488–499.
   PubMed Web of Science ®Google Scholar
• Dong J, Zhou GH, Tang DF, et al. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth. J Cancer Res Clin Oncol. 2012;138:2079–2084.
   PubMed Web of Science ®Google Scholar
• Sun S, Lee D, Leung GKK. Chemoresistance in Glioma. Humana Press; 2013;312:243–270.
   Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996.
   PubMed Web of Science ®Google Scholar
• Roullin VG, Deverre JR, Lemaire L, et al. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Eur J Pharm Biopharm. 2002;53:293–299.
   PubMed Web of Science ®Google Scholar
• White E, Bienemann A, Malone J, et al. An evaluation of the relationships between catheter design and tissue mechanics in achieving high-flow convection-enhanced delivery. J Neurosci Methods. 2011;199:87–97.
   PubMed Web of Science ®Google Scholar
• MacKay JA, Deen DF, Szoka FC. Jr. Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res. 2005;1035:139–153.
   PubMed Web of Science ®Google Scholar
• Saito R, Krauze MT, Noble CO, et al. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery. J Neurosci Methods. 2006;154:225–232.
   PubMed Web of Science ®Google Scholar
• Reardon DA, Wen PY. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents. Oncologist. 2006;11:152–164.
   PubMed Web of Science ®Google Scholar
• Choueiri TK, Raghavan D. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties. Nat Rev Clin Oncol. 2008;5:444–454.
   Google Scholar
• Delbaldo C, Michiels S, Syz N, et al. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis. JAMA. 2004;292:470–484.
   PubMed Web of Science ®Google Scholar
• Minniti G, Muni R, Lanzetta G, et al. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res. 2009;29:5171–5184.
   PubMed Web of Science ®Google Scholar
• Hou LC, Veeravagu A, Hsu AR, et al. Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus. 2006;20:E3.
   Google Scholar